Back to Search
Start Over
Supplementary figure 3 from Efficacy of Anti-RON Antibody Zt/g4–Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary figure 3. Effect of Zt/g4-DM1 on reduction of cell viability in CRC cell lines expressing different numbers of RON receptor
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....cd9d51312b1b6fb86cc0211148fe90d6
- Full Text :
- https://doi.org/10.1158/1078-0432.22455405.v1